Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDIV 1

Study Type

Observational 1

Sponsor

Conditions

Lymphoma 8Leukemia 7Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 5Graft vs Host Disease 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Burkitt Lymphoma 4Lymphoma, Large-Cell, Anaplastic 3Congenital Abnormalities 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Neoplasms 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Immunoblastic Lymphadenopathy 2Breast Neoplasms 2Unspecified Childhood Solid Tumor, Protocol Specific 1Sezary Syndrome 1Retinoblastoma 1Recurrence 1

Interventions

Pyridostigmine Bromide 4Tacrolimus 2Prednisone 2Mycophenolic Acid 2tocilizumab 1sargramostim 1Thymectomy 1Tablets 1Steroids 1Sternotomy 1Rituximab 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Granulocyte-Macrophage Colony-Stimulating Factor 1Exercise 1Data Collection 1Cyclosporine 1Cyclophosphamide 1Azathioprine 1Amifampridine 1Alkalies 1Albuterol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myasthenia Gravis × Cyclosporine × Clear all
NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡